Early Relapsed Multiple Myeloma: What’s Changing in 2025 | Research Breakthroughs from ASCO & EHA

Are you or a loved one navigating a multiple myeloma relapse after one to three prior treatments? In this video, Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, shares the top 3 breakthroughs in early relapse multiple myeloma care presented at ASCO and EHA 2025. Discover how new therapies and innovative delivery methods are transforming outcomes and quality of life.

Topics Covered:
0:00 - Intro: Why early relapse matters
2:00 - Blenrep (belantamab mafodotin) returns: DREAMM-7 & DREAMM-8 trial highlights
4:36 - On-body injector (OBI) for isatuximab: a game-changer for home-based care
6:05 - Rise of bispecific antibodies in early relapse: teclistamab, talquetamab, elranatamab, linvoseltamab
7:18 - What these updates mean for treatment decisions

Subscribe for weekly updates on myeloma research, treatment, and patient support. Have a question that needs more personalized support? Call us! We’re here for you. The IMF’s InfoLine is available to answer your myeloma-related questions and concerns. Call us at 1-818-487-7455, email us at [email protected], or schedule your call at a time that works best for you at: www.myeloma.org/infoline.
_______________
Improving Lives | Finding the Cure

Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.

Subscribe to our channel:    / imfmyeloma  

Visit our website at: https://www.myeloma.org

Find us online:
Facebook: @myeloma |   / myeloma  
X/Twitter: @IMFMyeloma |   / imfmyeloma  
Instagram: @imfmyeloma |   / imfmyeloma  
LinkedIn:   / international-myeloma-foundation  

Support the IMF | Donate Now! https://fundraise.myeloma.org/give/52...

Category
Nonprofits & Activism
License
Standard YouTube License

The International Myeloma Foundation is committed to accessibility for all. That’s why all English-language videos uploaded to our YouTube channel feature human-transcribed closed captioning. This ensures more accurate captions for viewers who are Deaf or hard of hearing and improves the quality of automatic translations into other languages for our global audience.